Z

Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332

Watchlist Manager
Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
Watchlist
Price: 12.59 CNY -1.49% Market Closed
Market Cap: 12.5B CNY
Have any thoughts about
Zhejiang Xianju Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Zhejiang Xianju Pharmaceutical Co Ltd

Wall Street analysts forecast Zhejiang Xianju Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhejiang Xianju Pharmaceutical Co Ltd is 16.42 CNY with a low forecast of 13.82 CNY and a high forecast of 18.56 CNY.

Lowest
Price Target
13.82 CNY
10% Upside
Average
Price Target
16.42 CNY
30% Upside
Highest
Price Target
18.56 CNY
47% Upside
Zhejiang Xianju Pharmaceutical Co Ltd Competitors:
Price Targets
BMY
Bristol-Myers Squibb Co
7% Downside
CLN
Celon Pharma SA
12% Downside
PPLPHARMA
Piramal Pharma Ltd
0% Downside
HROW
Harrow Health Inc
38% Upside
2DT
Amneal Pharmaceuticals Inc
9% Upside
PHAT
Phathom Pharmaceuticals Inc
148% Upside
DERM
Journey Medical Corp
82% Upside

Revenue
Forecast

Revenue Estimate
Zhejiang Xianju Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang Xianju Pharmaceutical Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 12%.

7%
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Zhejiang Xianju Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang Xianju Pharmaceutical Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 23%.

19%
Past Growth
23%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Zhejiang Xianju Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang Xianju Pharmaceutical Co Ltd's net income is 23%. The projected CAGR for the next 3 years is 21%.

23%
Past Growth
21%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhejiang Xianju Pharmaceutical Co Ltd's stock price target?
Price Target
16.42 CNY

According to Wall Street analysts, the average 1-year price target for Zhejiang Xianju Pharmaceutical Co Ltd is 16.42 CNY with a low forecast of 13.82 CNY and a high forecast of 18.56 CNY.

What is Zhejiang Xianju Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Zhejiang Xianju Pharmaceutical Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 12%.

What is Zhejiang Xianju Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for Zhejiang Xianju Pharmaceutical Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 23%.

What is Zhejiang Xianju Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
21%

For the last 8 years the compound annual growth rate for Zhejiang Xianju Pharmaceutical Co Ltd's net income is 23%. The projected CAGR for the next 3 years is 21%.

Back to Top